Marktprognose für Schnelltests im Nahen Osten und Afrika bis 2030 – Regionale Analyse – nach Typ (Schnelltests auf Antigene, Schnelltests auf Antikörper und andere), Produkt (rezeptfreie Schnelltests und professionelle Schnelltests), Technologie (Lateralflusstest, Festphasentest, Agglutination, Immunospot-Test und auf zellulären Komponenten basierend), Anwendung (Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere) und Endbenutzer (Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere)

BMIRE00030472 | Pages: 145 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Der Markt für Schnelltestkits im Nahen Osten und Afrika wurde im Jahr 2022 auf 849,64 Millionen US-Dollar geschätzt und soll bis 2030 1.174,76 Millionen US-Dollar erreichen; von 2022 bis 2030 wird eine durchschnittliche jährliche Wachstumsrate von 4,1 % erwartet.

Innovationen bei schnellen Antigentests beflügeln den Markt für Schnelltestkits im Nahen Osten und Afrika

Multiplex-Schnell-Antigentests basieren auf mehrfarbigen Nanopartikeln und kreuzreaktiven Antikörpern, und diese Testkits können kostengünstig entwickelt werden. Wenn verschiedene Atemwegserreger gleichzeitig in einem Wirtskörper zirkulieren, helfen schnelle Multiplex-Diagnosetests den Gesundheitsdienstleistern, ihre Patienten effektiver zu überwachen. Diese Tests können dazu beitragen, Fehldiagnosen zu vermeiden, die aufgrund überlappender klinischer Symptome möglich sind. Indem sie diagnostische Unsicherheiten beseitigen, helfen sie den Gesundheitsdienstleistern, angemessene Entscheidungen über den Beginn und das Ende antimikrobieller Therapien zu treffen. Im Vergleich zu Antigentestkits für einzelne Proben können Multiplex-Antigen-Schnelltests viele Atemwegsviren aus einer einzigen Probe erkennen, ohne Kompromisse bei der Qualität der Ergebnisse einzugehen. Daher zeichnen sich Innovationen wie Multiplex-Antigen-Schnelltests als zukünftige Trends auf dem Markt für Schnelltestkits ab.

Marktübersicht für Schnelltestkits im Nahen Osten und Afrika

Der Markt für Schnelltestkits in Saudi-Arabien wächst rasant, getrieben von der riesigen Bevölkerungsbasis und der Zunahme von Infektionskrankheiten. Laut WHO machten Grippe und Lungenentzündung 4,58 % aller Todesfälle im Land aus. Um der steigenden Zahl der Grippefälle zu begegnen, erfüllte das Public Health Laboratory in Saudi-Arabien alle Anforderungen der WHO, um als nationales Grippezentrum für Saudi-Arabien anerkannt zu werden. Laut Gulf News wurden im Jahr 2020 in Saudi-Arabien 3.367 Menschen mit Malaria infiziert.

Nach Angaben der International Diabetes Federation (IDF) gab es in Saudi-Arabien im Jahr 2021 insgesamt 4,27 Millionen Diabetesfälle bei Erwachsenen. Daher wird erwartet, dass die steigende Zahl der Diabetesfälle das Wachstum des Marktes für Schnelltestkits im Land vorantreiben wird.

Umsatz und Prognose für den Markt für Schnelltestkits im Nahen Osten und Afrika bis 2030 (in Mio. USD)

Segmentierung des Marktes für Schnelltestkits im Nahen Osten und Afrika

Der Markt für Schnelltestkits im Nahen Osten und Afrika ist nach Typ, Produkt, Technologie, Anwendung, Endbenutzer und Land segmentiert. Basierend auf dem Typ ist der Markt für Schnelltestkits im Nahen Osten und Afrika in schnelle Antigentests, schnelle Antikörpertests und andere segmentiert. Das Segment der schnellen Antigentests hatte 2022 den größten Marktanteil.

In Bezug auf das Produkt ist der Markt für Schnelltestkits im Nahen Osten und Afrika in rezeptfreie Schnelltestkits und professionelle Schnelltestkits unterteilt. Das Segment der rezeptfreien Schnelltestkits hatte 2022 einen größeren Marktanteil.

Nach Technologie ist der Markt für Schnelltestkits im Nahen Osten und Afrika in Lateral-Flow-Assay, Festphasen-, Agglutinations-, Immunospot-Assay und zelluläre Komponenten-basierte Tests unterteilt. Das Segment der Lateral-Flow-Assays hatte 2022 den größten Marktanteil.

Basierend auf der Anwendung ist der Markt für Schnelltestkits im Nahen Osten und Afrika in Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere unterteilt. Das Segment Blutzuckertests hatte 2022 den größten Marktanteil.

In Bezug auf den Endverbraucher ist der Markt für Schnelltestkits im Nahen Osten und Afrika in Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere unterteilt. Das Segment Krankenhäuser und Kliniken hatte 2022 den größten Marktanteil.

Nach Ländern ist der Markt für Schnelltestkits im Nahen Osten und Afrika in Saudi-Arabien, Südafrika, die Vereinigten Arabischen Emirate und den Rest des Nahen Ostens und Afrikas unterteilt. Saudi-Arabien dominierte 2022 den Marktanteil der Schnelltestkits im Nahen Osten und Afrika.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratoriess, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA und Beckman Coulter Inc sind einige der führenden Akteure auf dem Markt für Schnelltestkits im Nahen Osten und Afrika.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Rapid Test Kits Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Prevalence of Genetic and Infectious Diseases

4.1.2 Strategic Initiatives by Manufacturers

4.2 Market Restraints

4.2.1 Uncertainties Related to Accuracy of Results

4.3 Market Opportunities

4.3.1 Increasing Preference for PCR Techniques

4.4 Future Trends

4.4.1 Innovations in Rapid Antigen Tests

4.5 Impact Analysis

5. Rapid Test Kits Market - Middle East & Africa Market Analysis

5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Rapid Test Kits Market Analysis - by Type

6.1 Overview

6.2 Rapid Antigen Testing

6.2.1 Overview

6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Rapid Antibody Testing

6.3.1 Overview

6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Rapid Test Kits Market Analysis - by Product

7.1 Overview

7.2 Over-the-Counter Rapid Testing Kit

7.2.1 Overview

7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Professional Rapid Testing Kit

7.3.1 Overview

7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Rapid Test Kits Market Analysis - by Technology

8.1 Overview

8.2 Lateral Flow Assay

8.2.1 Overview

8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Solid Phase

8.3.1 Overview

8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Agglutination

8.4.1 Overview

8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Immunospot Assay

8.5.1 Overview

8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Cellular-Component Based

8.6.1 Overview

8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Rapid Test Kits Market Analysis - by Application

9.1 Overview

9.2 Blood Glucose Testing

9.2.1 Overview

9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Infectious Disease Testing

9.3.1 Overview

9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)

9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Cardiometabolic Testing

9.4.1 Overview

9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Pregnancy and Fertility

9.5.1 Overview

9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Rapid Test Kits Market Analysis - by End User

10.1 Overview

10.2 Hospital and Clinics

10.2.1 Overview

10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.3 Diagnostic Centers

10.3.1 Overview

10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Home-Care

10.4.1 Overview

10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Others

10.5.1 Overview

10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Middle East & Africa Rapid Test Kits Market - Country Analysis

11.1 Middle East & Africa

11.1.1 Overview

11.1.2 Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country

11.1.2.1 Saudi Arabia

11.1.2.1.1 Overview

11.1.2.2 Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.2.2.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Type

11.1.2.2.2 Saudi Arabia: Rapid Test Kits Market Breakdown, by Product

11.1.2.2.3 Saudi Arabia: Rapid Test Kits Market Breakdown, by Technology

11.1.2.2.4 Saudi Arabia: Rapid Test Kits Market Breakdown, by Application

11.1.2.2.4.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.2.2.5 Saudi Arabia: Rapid Test Kits Market Breakdown, by End User

11.1.2.3 South Africa

11.1.2.3.1 Overview

11.1.2.4 South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.2.4.1 South Africa: Rapid Test Kits Market Breakdown, by Type

11.1.2.4.2 South Africa: Rapid Test Kits Market Breakdown, by Product

11.1.2.4.3 South Africa: Rapid Test Kits Market Breakdown, by Technology

11.1.2.4.4 South Africa: Rapid Test Kits Market Breakdown, by Application

11.1.2.4.4.1 South Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.2.4.5 South Africa: Rapid Test Kits Market Breakdown, by End User

11.1.2.5 United Arab Emirates

11.1.2.5.1 Overview

11.1.2.6 United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.2.6.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Type

11.1.2.6.2 United Arab Emirates: Rapid Test Kits Market Breakdown, by Product

11.1.2.6.3 United Arab Emirates: Rapid Test Kits Market Breakdown, by Technology

11.1.2.6.4 United Arab Emirates: Rapid Test Kits Market Breakdown, by Application

11.1.2.6.4.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.2.6.5 United Arab Emirates: Rapid Test Kits Market Breakdown, by End User

11.1.2.7 Rest of Middle East & Africa

11.1.2.7.1 Overview

11.1.2.8 Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11.1.2.8.1 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Type

11.1.2.8.2 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Product

11.1.2.8.3 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Technology

11.1.2.8.4 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Application

11.1.2.8.4.1 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing

11.1.2.8.5 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Rapid Test Kit Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Becton Dickinson and Co

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 ARKRAY Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Fujirebio Europe NV

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 bioMerieux SA

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Cepheid

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Meril Life Sciences Pvt Ltd

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 QIAGEN NV

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Guangzhou Wondfo Biotech Co Ltd

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Abbott Laboratories

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Bio-Rad Laboratories Inc

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 Hologic Inc

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

13.13 DiaSorin SpA

13.13.1 Key Facts

13.13.2 Business Description

13.13.3 Products and Services

13.13.4 Financial Overview

13.13.5 SWOT Analysis

13.13.6 Key Developments

13.14 Premier Medical Corp Pvt Ltd

13.14.1 Key Facts

13.14.2 Business Description

13.14.3 Products and Services

13.14.4 Financial Overview

13.14.5 SWOT Analysis

13.14.6 Key Developments

13.15 Beckman Coulter Inc

13.15.1 Key Facts

13.15.2 Business Description

13.15.3 Products and Services

13.15.4 Financial Overview

13.15.5 SWOT Analysis

13.15.6 Key Developments

14. Appendix

14.1 About The Insight Partners

List of Tables

Table 1. Rapid Test Kits Market Segmentation

Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 4. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 5. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 6. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 7. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 8. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 10. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 11. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 12. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 13. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 14. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 16. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 17. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 18. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 20. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 21. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type

Table 22. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 23. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology

Table 24. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 25. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing

Table 26. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 27. Recent Inorganic Growth Strategies in the Rapid Test Kit Market

Table 28. Recent Organic Growth Strategies in the Rapid Test Kit Market

List of Figures

Figure 1. Rapid Test Kits Market Segmentation, By Country

Figure 2. Rapid Test Kits Market: Key Industry Dynamics

Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints

Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)

Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)

Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)

Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)

Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)

Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Middle East & Africa: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)

Figure 30. Middle East & Africa: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 31. Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 32. South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 33. United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 34. Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)

Figure 35. Growth Strategies in the Rapid Test Kit Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. Guangzhou Wondfo Biotech Co Ltd
10. Abbott Laboratories
11. Bio-Rad Laboratories Inc
12. Hologic Inc
13. Premier Medical Corp Pvt Ltd
14. DiaSorin SpA
15. Beckman Coulter Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa rapid test kit market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa rapid test kit market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440